Summary Q1 FY22

Resurgent traditional retail sales underpin 112% YoY growth in cash receipts

  • Strong customer receipts ($1.1m) and invoiced sales ($1.2m) of IQbuds² MAX & accessories.
  • Direct To Consumer (DTC) sales continue to deliver, particularly Australia.
  • Resurgent Traditional Retail sales growth in US, as retail re-opens post COVID.
  • Diversified sales channel has Nuheara well-positioned to continue growth.
  • Traditional Retail sales for October 2021 already exceed total for Q1 FY22.
  • Preparing to further scale as a medical device company, with clinical trials of self-fit hearing aids backed by new US OTC hearing legislation.

Click here to view the 2021FY Q1 results slides.

 

October 27th, 2021